Valor Compounding Pharmacy Uses Technology to Better Serve Clients in Challenging Times

BERKELEY, Calif., July 27, 2020 /PRNewswire/ — A quality-based program is vital in every compounding pharmacy to ensure that each preparation is compounded properly and is stable for its expected duration of use. At Valor, we have a comprehensive, systematic, and proactive approach to continuously improve everything that may, directly or indirectly, influence the quality of a preparation or service. Rick Niemi, Valor CEO says, “Building a world-class quality management system was just one of our top initiatives this year and it couldn’t have come at a better time as we expand our services into other states. Christine Stephanos, our President and Chief Pharmacy Officer, has done an amazing job putting this in place for Valor.”

One of our continuous improvement efforts was to assemble a needs assessment for a quality management system software that would document measures Valor has taken to improve quality from concept to customer.

Our main objectives were:

  • Reduce risk
    Improved product quality by managing all processes and data on a single platform
  • Ensure compliance
    Collaborate on and create company-wide policies, procedures, and SOPs
  • Reduce errors
    Boost employee productivity by eliminating manual data entry and double-checking of data
  • Design for quality
    Leverage customer insights early in the product design process to improve product quality
  • Manage complaints
    Keep customers safe by having up-to-date data at your fingertips
  • Keep training records
    Assign and track all training records in one place to ensure compliance

After assessing multiple softwares, we are proud to announce our partnership with Propel. Propel provides the only cloud-based quality management software solution that seamlessly connects with our CRM, and service platforms to create a true closed feedback loop that seamlessly integrates product realization, quality processes, and customer complaints. “Continuous performance improvement is integral to compounding pharmacy operations and Propel will allow us to seamlessly address product quality, processes, and customer concerns for better outcomes,” says Christine.

About Valor Compounding Pharmacy
Valor Compounding Pharmacy™, Inc. is a multi-state licensed 503A facility housing both sterile and non-sterile laboratories, located in Berkeley, CA. Valor is a specialized pharmacy that makes custom medications to meet the unique needs of the individual patient. Our goal is to reinvent pharmacy from a reactive vendor to a proactive partner in patient health care. We do that by optimizing turnaround time, being data driven, and by reducing patient anxiety. Our focus is on non-sterile and sterile, hazardous and non-hazardous compounded medication, and we work with a network of providers, patients, health systems / institutions, and research scientists in multiple states in the United States.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/valor-compounding-pharmacy-uses-technology-to-better-serve-clients-in-challenging-times-301099630.html

SOURCE Valor Compounding Pharmacy

Staff

Recent Posts

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey’s…

9 hours ago

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

AUSTIN, Texas--(BUSINESS WIRE)--Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships…

9 hours ago

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

12 hours ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

12 hours ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

12 hours ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

15 hours ago